Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

      MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

      Meghna A Singhania3 April 2019 4:30 PM IST
      New Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
      CDSCO calls for crackdown on Buclizine sales; Mankind Pharma taken to court: Report

      CDSCO calls for crackdown on Buclizine sales; Mankind Pharma taken to court: Report

      Meghna A Singhania3 April 2019 11:45 AM IST
      Those found manufacturing, selling or distributing buclizine on or after December 13 without adhering to the orders given by CDSCO, will be liable for...
      Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

      Price Fixation: NPPA revises ceiling prices of 16 drugs including Condoms ; Details

      Meghna A Singhania2 April 2019 12:34 PM IST
      New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling...
      Price Fixation: NPPA revises ceiling price of 8 IV fluids including Glucose; Details

      Price Fixation: NPPA revises ceiling price of 8 IV fluids including Glucose; Details

      Meghna A Singhania2 April 2019 11:45 AM IST
      NEW DELHI: Through a recent official release, National Pharmaceutical Pricing Authority (NPPA) has informed about the revision in the ceiling price of...
      NPPA revises price of Coronary Stents; Check out Details

      NPPA revises price of Coronary Stents; Check out Details

      Meghna A Singhania1 April 2019 1:21 PM IST
      New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), has revised the ceiling price of Coronary Stents....
      Shocking: Woman health officer shot dead for Cancelling Chemist Licence

      Shocking: Woman health officer shot dead for Cancelling Chemist Licence

      Meghna A Singhania1 April 2019 11:28 AM IST
      Kharar: In an appalling incident, a woman officer, posted as Zonal Licensing Authority with the Drug and Food Chemical Laboratory in the state was...
      Government extends deadline to impose high import duties on 29 US products till May 2

      Government extends deadline to impose high import duties on 29 US products till May 2

      Meghna A Singhania1 April 2019 10:00 AM IST
      The government has extended this deadline over half a dozen times since June 2018, when it decided to impose these duties in retaliation to a move by...
      Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark

      Diabetes Treatment: CDSCO expert panel marketing authorization Nod to Glenmark's SGLT2 Inhibitor Remogliflozin etabonate

      Meghna A Singhania31 March 2019 1:39 PM IST
      New Delhi: Mumbai-based Glenmark Pharmaceuticals Limited recently received the permission from the IND Committee of the Central Drugs Standard...
      Refix Ceiling Price of Tetanus Toxoid Vaccine: DoP directs NPPA

      Refix Ceiling Price of Tetanus Toxoid Vaccine: DoP directs NPPA

      Meghna A Singhania30 March 2019 2:03 PM IST
      New Delhi: The Department of Pharmaceuticals (DoP) has accepted the review petition of Biological E Limited against price fixation of Tetanus Toxoid...
      JnJ Faulty Hip Implants: 7 more patients found fit for compensation

      JnJ Faulty Hip Implants: 7 more patients found fit for compensation

      Meghna A Singhania30 March 2019 1:15 PM IST
      Mumbai: Several patients who claim to be suffering due to faulty hip implants manufactured by Johnson and Johnson (JnJ) have been claiming...
      Singh Brothers booked under IPC 420 for Rs 2397 crore fraud

      Singh Brothers booked under IPC 420 for Rs 2397 crore fraud

      Meghna A Singhania29 March 2019 2:56 PM IST
      New Delhi: Erstwhile promoters of Religare Enterprises Limited (REL), Malvinder Mohan Singh and Shivinder Mohan Singh have been booked by the Delhi...
      FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI

      FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI

      Meghna A Singhania27 March 2019 4:48 PM IST
      New Delhi: Manufacturers of Fixed Dose Combinations drugs ( FDC drugs) which have declared rational and approved by Drugs Controller General India...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok